THE IMPORTANCE OF BODY COMPOSITION MEASUREMENTS DURING LENVATINIB TREATMENT IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Yamaoka, Kenji [1 ]
Kawaoka, Tomokazu [1 ]
Kosaka, Masanari [1 ]
Johira, Yusuke [1 ]
Shirane, Yuki [1 ]
Miura, Ryoichi [1 ]
Yano, Shigeki [1 ]
Murakami, Serami [1 ]
Amioka, Kei [1 ]
Naruto, Kensuke [1 ]
Ando, Yuwa [1 ]
Kosaka, Yumi [1 ]
Uchikawa, Shinsuke [1 ]
Kodama, Kenichiro [1 ]
Uchida, Takuro [1 ]
Fujino, Hatsue [1 ]
Ono, Atsushi [1 ]
Nakahara, Takashi [1 ]
Murakami, Eisuke [1 ]
Okamoto, Wataru [2 ]
Yamauchi, Masami [1 ]
Miki, Daiki [1 ]
Imamura, Michio [1 ]
Chayama, Kazuaki [3 ]
Aikata, Hiroshi [1 ]
机构：
[1] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan
[2] Hiroshima Univ, Canc Treatment Ctr, Hiroshima, Japan
[3] Hiroshima Univ, Dept Collaborat Res Lab Med Innovat, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4508
引用
收藏
页码：S1386 / S1387
页数：2
相关论文
共 50 条
  • [1] The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment
    Yamaoka, Kenji
    Kodama, Kenichiro
    Kawaoka, Tomokazu
    Kosaka, Masanari
    Johira, Yusuke
    Shirane, Yuki
    Miura, Ryoichi
    Yano, Shigeki
    Murakami, Serami
    Amioka, Kei
    Naruto, Kensuke
    Ando, Yuwa
    Kosaka, Yumi
    Uchikawa, Shinsuke
    Uchida, Takuro
    Fujino, Hatsue
    Nakahara, Takashi
    Murakami, Eisuke
    Okamoto, Wataru
    Yamauchi, Masami
    Miki, Daiki
    Imamura, Michio
    Takahashi, Shoichi
    Nagao, Akiko
    Chayama, Kazuaki
    Aikata, Hiroshi
    PLOS ONE, 2022, 17 (01):
  • [2] Changes in Body Composition Predict the Time to Treatment Failure of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma: A Pilot Retrospective Study
    Yamamoto, Takafumi
    Imai, Norihiro
    Kuzuya, Teiji
    Yokoyama, Shinya
    Yamamoto, Kenta
    Ito, Takanori
    Ishizu, Yoji
    Honda, Takashi
    Ishigami, Masatoshi
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (09): : 3118 - 3127
  • [3] The importance of regorafenib and lenvatinib in the treatment of hepatocellular carcinoma
    Cihan, Yasemin Benderli
    JOURNAL OF BUON, 2019, 24 (02): : 867 - 867
  • [4] Surgical Intervention After Lenvatinib Treatment in Patients With Advanced Hepatocellular Carcinoma
    Okuno, Masayuki
    Hatano, Etsuro
    Tada, Masaharu
    Nishimura, Takashi
    Okamoto, Tomohiro
    Sueoka, Hideaki
    Iida, Kenjiro
    Nakamura, Ikuo
    Iijima, Hiroko
    Hirono, Seiko
    ANTICANCER RESEARCH, 2024, 44 (04) : 1727 - 1737
  • [5] Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma
    Legros, Laurence
    Pascale, Alina
    Guettier, Catherine
    Eftekhari, Pirayeh
    Ben Merabet, Yasmina
    Stang, Maryse
    Bossevot, Rachel
    Goldschmidt, Emma
    Ulusakarya, Ayhan
    Morisset, Stephane
    Lewin, Maite
    Samuel, Didier
    Rosmorduc, Olivier
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 91 (04) : 337 - 344
  • [6] Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma
    Laurence Legros
    Alina Pascale
    Catherine Guettier
    Pirayeh Eftekhari
    Yasmina Ben Merabet
    Maryse Stang
    Rachel Bossevot
    Emma Goldschmidt
    Ayhan Ulusakarya
    Stephane Morisset
    Maïté Lewin
    Didier Samuel
    Olivier Rosmorduc
    Cancer Chemotherapy and Pharmacology, 2023, 91 : 337 - 344
  • [7] Lenvatinib in Advanced Hepatocellular Carcinoma
    Kudo, Masatoshi
    LIVER CANCER, 2017, 6 (04) : 253 - 263
  • [8] Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
    Ikeda, Masafumi
    Okusaka, Takuji
    Mitsunaga, Shuichi
    Ueno, Hideki
    Tamai, Toshiyuki
    Suzuki, Takuya
    Hayato, Seiichi
    Kadowaki, Tadashi
    Okita, Kiwamu
    Kumada, Hiromitsu
    CLINICAL CANCER RESEARCH, 2016, 22 (06) : 1385 - 1394
  • [9] Posttreatment after lenvatinib in patients with advanced hepatocellular carcinoma
    Koroki, Keisuke
    Kanogawa, Naoya
    Maruta, Susumu
    Ogasawara, Sadahisa
    Obu, Masamichi
    Itokawa, Norio
    Inoue, Masanori
    Haga, Yuki
    Okabe, Shinichiro
    Seki, Atsuyoshi
    Atsukawa, Masanori
    Itobayashi, Ei
    Ito, Kenji
    Mizumoto, Hideaki
    Kobayashi, Kazufumi
    Kondo, Takayuki
    Suzuki, Eiichiro
    Chiba, Tetsuhiro
    Arai, Makoto
    Kato, Naoya
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [10] Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
    Koroki, Keisuke
    Kanogawa, Naoya
    Maruta, Susumu
    Ogasawara, Sadahisa
    Iino, Yotaro
    Obu, Masamichi
    Okubo, Tomomi
    Itokawa, Norio
    Maeda, Takahiro
    Inoue, Masanori
    Haga, Yuki
    Seki, Atsuyoshi
    Okabe, Shinichiro
    Koma, Yoshihiro
    Azemoto, Ryosaku
    Atsukawa, Masanori
    Itobayashi, Ei
    Ito, Kenji
    Sugiura, Nobuyuki
    Mizumoto, Hideaki
    Unozawa, Hidemi
    Iwanaga, Terunao
    Sakuma, Takafumi
    Fujita, Naoto
    Kanzaki, Hiroaki
    Kobayashi, Kazufumi
    Kiyono, Soichiro
    Nakamura, Masato
    Saito, Tomoko
    Kondo, Takayuki
    Suzuki, Eiichiro
    Ooka, Yoshihiko
    Nakamoto, Shingo
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Arai, Makoto
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Kato, Jun
    Kato, Naoya
    LIVER CANCER, 2021, 10 (05) : 473 - 484
12345